AEON Biopharma prices upsized $13.75M public offering with milestone warrants for potential $29.6M additional proceeds

AEON Biopharma, Inc.

Offering of 42,688,606 shares (or pre-funded warrants) plus two-year and five-year milestone warrants at combined price of $0.3221 per share.
Gross proceeds of ~$13.75M; up to $29.6M more if all milestone warrants exercised for cash.
Net proceeds of ~$12.2M to be used for working capital and ABP-450 biosimilar testing.
Underwriters granted 30-day over-allotment option for up to 6,403,290 additional shares/warrants.
Offering closed July 15, 2026; lock-up agreements for 90 days from closing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.